| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/29/2008 | US20080125588 Via catalyst such as tetrakis(triphenylphosphine)palladium; for treating cell proliferative disorders |
| 05/29/2008 | US20080125460 inducible nitric oxide synthase inhibitors; acute or chronic inflammatory diseases of of peripheral organs and the central nervous system; 6-pyridinyl imidazo-[4,5-b]pyridine compounds; 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-(pyridin-4-yl)-3H-imidazo-[4,5-b]pyridine |
| 05/29/2008 | US20080125459 N-(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 05/29/2008 | US20080125458 Pradofloxacin trihydrate; thermodynamically stable and is not converted to other crystal forms even during prolonged storage; non-hygroscopic |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125451 Vinorelbine derivatives |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080124751 Combinatorial rosamine library and uses thereof |
| 05/29/2008 | CA2670362A1 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 05/29/2008 | CA2670202A1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 05/29/2008 | CA2670165A1 2- [ (2-substituted) -ind0lizin-3-yl] -2-oxo-acetamide derivatives as antifungal agents |
| 05/29/2008 | CA2670031A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | CA2669579A1 5-sulfanylmethyl-pyrazolo [1,5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists |
| 05/29/2008 | CA2669199A1 Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile |
| 05/28/2008 | EP1925618A1 Imidazopyridine-based compounds and organic light emitting diode including organic layer comprising the imidazopyridine-based compounds |
| 05/28/2008 | EP1925617A1 Heterocyclic compound, and production process and use thereof |
| 05/28/2008 | EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/28/2008 | EP1925297A1 Method for preparing microparticles having a selected polymer molecular weight |
| 05/28/2008 | EP1924583A2 Process for the synthesis of cmhtp and intermediates thereof |
| 05/28/2008 | EP1924582A2 Amide and carbamate derivatives of alkyl substituted n-[4-(4-amino-1h-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamides and methods |
| 05/28/2008 | EP1924581A1 Hydroxy substituted 1h-imidazopyridines and methods |
| 05/28/2008 | EP1924580A1 Non-steroidal compounds useful as glucocorticoid receptor modulators |
| 05/28/2008 | EP1924562A2 Pyrazolone derivatives |
| 05/28/2008 | EP1924557A2 Carbazole derivatives |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 05/28/2008 | EP1501507B1 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/28/2008 | EP1404668B1 Variolin derivatives and their use as antitumor agents |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | CN101189241A Thienopyridine derivative, quinoline derivative, and quinazoline derivative having c-Met autophosphorylation inhibiting activity |
| 05/28/2008 | CN101189237A Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
| 05/28/2008 | CN101189236A Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 05/28/2008 | CN101189235A 2-pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 05/28/2008 | CN101189234A Heterobicyclic inhibitors of HCV |
| 05/28/2008 | CN101189233A Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 05/28/2008 | CN101189227A New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 05/28/2008 | CN101189012A Phenyl and pyridyl LTA4H modulators |
| 05/28/2008 | CN101186608A Imidazopyridine-based compound and organic light emitting diode including organic layer comprising the imidazopyridine-based compound |
| 05/28/2008 | CN100390173C Tricyclic compound |
| 05/28/2008 | CN100390172C Methane sulfonic acid dolasetron crystallographic form and its preparation method |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390146C Process for making risperidone and intermediates therefor |
| 05/27/2008 | US7378524 e.g., 6-chloro-2-methyl-4-(N-(2-(N-(p-methoxyphenylsulfonyl)-N-(2-(2,5-dimethoxy-4-nitroanilinocarbonyl)ethyl)amino)ethyl)amino)quinoline; used to treat inflammatory and immune diseases by binding to CXCR3 receptors. |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378424 Derivatives of pyrimido[6, 1-A]isoquinolin-4-one |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/22/2008 | WO2008060907A2 Pyrrolo-pyridine kinase inhibitors |
| 05/22/2008 | WO2008060621A2 Aminopyrrolidines as chemokine receptor antagonists |
| 05/22/2008 | WO2008060487A2 Polymorphs of nicotinic intermediates |
| 05/22/2008 | WO2008060476A2 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/22/2008 | WO2008059714A1 Novel compounds with affinity for amyloid |
| 05/22/2008 | WO2008059521A2 Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin |
| 05/22/2008 | WO2008059267A1 Selective glycosidase inhibitors |
| 05/22/2008 | WO2008059238A1 Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer |
| 05/22/2008 | WO2008059223A2 Process for the synthesis of moxifloxacin hydrochloride |
| 05/22/2008 | WO2008043087A3 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 05/22/2008 | WO2008037881A3 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 05/22/2008 | WO2008022024A3 Imidazole amines as inhibitors of beta-secretase |
| 05/22/2008 | WO2007138431A3 Azabicyclic ether histamine-3 antagonists |
| 05/22/2008 | US20080119648 Histone deacetylase inhibitors |
| 05/22/2008 | US20080119524 Treating conditions related to Ras or Ras-like protein prenylation such as cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic disorders; amide-functional pyrazole compounds containing 2,2-dimethylcyclobutan-1,3-ylene moiety |
| 05/22/2008 | US20080119510 Substituted Imidazo [4,5-B] Pyridines As Inhibitors Of Gastric Acid Secretion |
| 05/22/2008 | US20080119509 Nontoxic; asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), eosinophilic granuloma, psoriasis |
| 05/22/2008 | US20080119507 Novel Isoindole Derivatives, Compositions Containing Same, Preparation Thereof and Pharmaceutical Uses Thereof in Particular as Inhibitors of Chaperone Protein HSP90 Activities |
| 05/22/2008 | US20080119502 Vinca derivatives |
| 05/22/2008 | US20080119500 Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 05/22/2008 | US20080119497 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/22/2008 | US20080119496 7-Substituted Purine Derivatives for Immunosuppression |
| 05/22/2008 | US20080119480 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 05/22/2008 | US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract |
| 05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
| 05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
| 05/22/2008 | US20080118560 Spray congealed 5-amido-7-benzyl(oxy or amino)imidazo[1,2-a]pyridines, at least one each of hydrophilic and hydrophobic matrix formers; antisecretory agents with improved water solubility, bioavailability and pharmacokinetics |
| 05/22/2008 | US20080116789 1, 5-naphthyridine compound and organic light-emitting device |
| 05/22/2008 | CA2669670A1 Nitrogen-containing heterocyclic compounds and methods of use thereof |
| 05/22/2008 | CA2669522A1 Novel compounds with affinity for amyloid |
| 05/22/2008 | CA2669427A1 Process for the synthesis of moxifloxacin hydrochloride |
| 05/22/2008 | CA2666327A1 Polymorphs of nicotinic intermediates |
| 05/21/2008 | EP1922320A1 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
| 05/21/2008 | EP1922319A2 Pure paliperidone and processes for preparing thereof |
| 05/21/2008 | EP1922318A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
| 05/21/2008 | EP1922317A2 Amide and carbamate derivatives of n-{2-ý4-amino-2- (ethoxymethyl)-1h-imidazoý4,5-c¨quinolin-1-yl¨-1,1-dimethylethyl}methanesulfonamide and methods |
| 05/21/2008 | EP1921917A2 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1599206A4 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 05/21/2008 | EP1456206B1 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 05/21/2008 | EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/21/2008 | EP1434773B1 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | DE102007053198A1 Photoinitiatoren für strahlungshärtbare Beschichtungsmassen Photoinitiators for radiation-curable coating compositions |
| 05/21/2008 | CN101184760A Heterocyclic spiro-compounds |
| 05/21/2008 | CN101184757A Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 05/21/2008 | CN101184756A Isoflavonoid dimers |
| 05/21/2008 | CN101184755A Peptidomimetic compounds and preparation of biologically active derivatives |
| 05/21/2008 | CN101184733A Novel piperidine carboxylic acid amide derivatives |
| 05/21/2008 | CN101184487A Bicyclic pyrazole compounds as antibacterial agents |
| 05/21/2008 | CN101184485A Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors |